Tofflon Science and Technology Group Co., Ltd. (SHE:300171)

China flag China · Delayed Price · Currency is CNY
13.19
-0.60 (-4.35%)
Apr 29, 2026, 3:04 PM CST
14.00%
Market Cap 10.04B
Revenue (ttm) 5.20B
Net Income (ttm) 207.76M
Shares Out 760.85M
EPS (ttm) 0.27
PE Ratio 50.73
Forward PE 26.65
Dividend 0.06 (0.44%)
Ex-Dividend Date Sep 25, 2025
Volume 17,804,810
Average Volume 6,746,310
Open 14.14
Previous Close 13.79
Day's Range 12.90 - 14.14
52-Week Range 11.48 - 20.37
Beta 0.54
RSI 32.08
Earnings Date Apr 29, 2026

About SHE:300171

Tofflon Science and Technology Group Co., Ltd. engages in the research, development, production, sales, and services of pharmaceutical equipment in China and internationally. It operates through four segments: Biotechnology, Preparation Equipment, Engineering, and Food Engineering. The company offers technological research, such as cell technology, complex preparation, injection, and OSD laboratory; instruments, including cell therapy and nucleic acid drugs instruments, and table reactor; cryopreservation system for seeds and biological samples... [Read more]

Sector Healthcare
Founded 1993
Employees 5,417
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 300171
Full Company Profile

Financial Performance

In 2025, SHE:300171's revenue was 5.23 billion, an increase of 4.45% compared to the previous year's 5.01 billion. Earnings were 200.38 million, an increase of 3.24%.

Financial Statements

News

There is no news available yet.